Winston Pharmaceuticals, Inc.
WPHM
$0.00
$0.000.00%
OTC PK
| 03/31/2010 | 12/31/2009 | ||||
|---|---|---|---|---|---|
| Revenue | -6.58% | -3.28% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.58% | -3.28% | |||
| Cost of Revenue | -5.78% | -40.59% | |||
| Gross Profit | -33.33% | 96.90% | |||
| SG&A Expenses | -18.63% | 18.09% | |||
| Depreciation & Amortization | -4.55% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.65% | -14.43% | |||
| Operating Income | 17.91% | 19.99% | |||
| Income Before Tax | 18.01% | 20.01% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 18.01% | 20.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 18.01% | 20.01% | |||
| EBIT | 17.91% | 19.99% | |||
| EBITDA | 17.96% | 20.06% | |||
| EPS Basic | 16.67% | 41.94% | |||
| Normalized Basic EPS | 17.78% | 41.56% | |||
| EPS Diluted | 16.67% | 41.94% | |||
| Normalized Diluted EPS | 17.78% | 41.56% | |||
| Average Basic Shares Outstanding | -0.22% | 36.86% | |||
| Average Diluted Shares Outstanding | -0.22% | 36.86% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||